SUMMARY
Expression of the interleukin-1 receptor type I (IL-1RI) co-receptor Toll-like and interleukin-1 receptor regulator (TILRR) is significantly increased in blood monocytes following myocardial infarction and in the atherosclerotic plaque, whereas levels in healthy tissue are low. TILRR association with IL-1RI at these sites causes aberrant acti- family are central to control of immunity and inflammation, and their importance in disease is well documented (1) (2) (3) (4) . Activation is induced by ligand binding and by association of systemspecific co-receptors, which regulate signal amplification and transcriptional activity (1, 4, 5) . Changes in co-receptor expression and causative mutations impact responses to infection, tissue damage and stress, and affect development of disease (5) .
Proteoglycans and glycosylated proteins act as co-receptors in a number of regulatory systems.
Recruited to the receptor complex, they control receptor function, ligand binding, and extracellular interactions associated with aberrant signal activation and disease (6) (7) (8) . The IL-1 receptor type I (IL-1RI), and its ligand, the cytokine IL-1, are potent activators of nuclear factor-kappa B (NF-kB) and
intrinsically linked with acute and chronic inflammation (9) . Dysregulation of NF-kB and IL-1-induced gene activity underlie development and progression of conditions such as atherosclerosis (10, 11) . Our earlier studies identified Toll-like and IL-1 receptor regulator (TILRR) (FREM1 isoform 2) (12), a cell surface proteoglycan, as an IL-1RI co-receptor (13, 14) . We have demonstrated that TILRR association with IL-1RI causes enhanced expression of IL-1RI and increased recruitment of the MyD88 adapter to the Toll/interleukin-1 receptor homology domain of IL-1RI (13) . Further, we have shown that the resulting in vitro studies (13, 14) . Using wellestablished models of vascular disease we demonstrate that TILRR KO and antibody blocking lead to reductions in monocyte activation, inflammatory gene activity, and disease progression, without causing development of vulnerable plaques. Taken together our results suggest that TILRR is a central regulator of inflammatory responses related to development of vascular disease, and that it may constitute a highly specific therapeutic target. These targeted embryonic stem clones were expanded and analyzed by long-range PCR for confirmation before using them for embryonic stem cell-morula aggregations (KSOM embryo culture medium, overnight, 37 C) and development of blastocysts for generation of chimeric animals.
Chimeric animals were bred with ROSA26-Flpe mice (Jax #003946, Jackson Laboratory, Bar Harbor, Maine) to remove the PGKneo cassette to generate the conditional knock-in mice, or Hprt-Cre mice (Jax #004302) to generate the global KO mice. C57BL/6J wild-type littermates were used as control mice.
Low-density lipoprotein receptor -/-/TILRR -/double KO mouse. Double knockout mice (TILRR -/-/LDLRR -/-) were bred using LDLR -/-(Jax 002207) and a conventional cross breeding strategy. Observed genotype ratios did not differ from those expected.
Apolipoprotein E (ApoE)-deficient (ApoE -/-) mice (Jax #2052) were obtained from the Jackson Laboratory. P C R g e n o t y p i n g . Ear clippings were lysed in 50-ml alkaline lysis reagent (95 C, 2 h) before addition of neutralization reagent (50 ml), and 1 ml used for each PCR reaction. Each reaction used 12.5 ml BioMixRed (2Â, Bioline), 0.6 ml of each primer (10 mM), and 1 ml of DNA in a total volume of 25 ml (Tables 1 to 4 R e s p o n s e t o i n j u r y . This was assessed using carotid ligation, as previously (17) . The right carotid artery of wild-type and TILRR KO mice was exposed and permanently ligated with a 6-0 suture just below the bifurcation. The contralateral artery received a sham ligation. Arteries were harvested from animals after 28 days following perfusion fixation.
Arteries were embedded in paraffin wax, sectioned and stained for morphometric analysis and immunohistochemistry. Smith et al. Abbreviations as in Tables 1 and 2 . En face staining of the whole aorta was carried out as described (21) . In brief, the aortas were perfused Protein tertiary structure models were viewed and modified in MolSoft ICM Browser and protein structure template quality scored (37, 38) . Figure 1 ), which demonstrated that TILRR deletion caused a reduction in activated blood monocytes from 28.13 AE 5.04% to 11.34 AE 1.81% ( Figure 1C) . AE 388 mm 2 to 971 AE 141 mm 2 ) ( Figures 2D and 2E) . Figure 3D) . Further, plaque levels in the descending aorta were reduced from 8.3 AE 2.5% to 1.9 AE 0.5% of the cross-sectional area of the vessel ( Figure 3E) . Figure 2C) . Levels, expressed relative to activities in cultures incubated with a nonspecific IgG control, were reduced from 1.00 AE 0.07 to Abbreviations as in Figure 1 . Figure 2D) . Figures 5C and 5D ). complex following blocking of the 448 residue, which is located within the predicted region of proteinprotein association (13, 14, 27) . A mechanism involving alterations in TILRR binding to the receptor complex is consistent with results from our previous studies, which show that TILRR function is dependent on its interaction with the signaling receptor (13) . It is also in agreement with effects of inhibiting co-receptor 
